Hidden drivers of low-dose pharmaceutical pollutant mixtures revealed by the novel GSA-QHTS screening method

• Published in: Science advances 2016-09, Vol.2 (9), p.e1601272-e1601272
• Main Authors: Rodea-Palomares, Ismael, Gonzalez-Pleiter, Miguel, Gonzalo, Soledad, Rosal, Roberto, Leganes, Francisco, Sabater, Sergi, Casellas, Maria, Muñoz-Carpena, Rafael, Fernández-Piñas, Francisca
• Format: Article
• Language: English
• Subjects: Bacteria - drug effects; Contaminants emergents en l'aigua; Drug-Related Side Effects and Adverse Reactions; Emerging contaminants in water; Environmental Monitoring; Environmental Pollutants - isolation & purification; Environmental Pollutants - toxicity; Environmental Studies; High-Throughput Screening Assays; Humans; Pharmaceutical Preparations - chemistry; Pharmaceutical Preparations - isolation & purification; SciAdv r-articles; Water Pollutants, Chemical - isolation & purification; Water Pollutants, Chemical - toxicity
• ISSN: 2375-2548; 2375-2548
• DOI: 10.1126/sciadv.1601272

The ecological impacts of emerging pollutants such as pharmaceuticals are not well understood. The lack of experimental approaches for the identification of pollutant effects in realistic settings (that is, low doses, complex mixtures, and variable environmental conditions) supports the widespread perception that these effects are often unpredictable. To address this, we developed a novel screening method (GSA-QHTS) that couples the computational power of global sensitivity analysis (GSA) with the experimental efficiency of quantitative high-throughput screening (QHTS). We present a case study where GSA-QHTS allowed for the identification of the main pharmaceutical pollutants (and their interactions), driving biological effects of low-dose complex mixtures at the microbial population level. The QHTS experiments involved the integrated analysis of nearly 2700 observations from an array of 180 unique low-dose mixtures, representing the most complex and data-rich experimental mixture effect assessment of main pharmaceutical pollutants to date. An ecological scaling-up experiment confirmed that this subset of pollutants also affects typical freshwater microbial community assemblages. Contrary to our expectations and challenging established scientific opinion, the bioactivity of the mixtures was not predicted by the null mixture models, and the main drivers that were identified by GSA-QHTS were overlooked by the current effect assessment scheme. Our results suggest that current chemical effect assessment methods overlook a substantial number of ecologically dangerous chemical pollutants and introduce a new operational framework for their systematic identification.